1. 2- [F] ftoretiltriazol-linked analog of [Tyr] oktreotata of formula (III) :, wherein R a, R d following structure : iLINKER represents a linker group of formula - (A) -, wherein each A independently represents -CR, -CR = CR-, -C≡C-, -CRCO-, -COCR-, -NRCO-, -CONR-, - NR (C = O) NR-, -NR (C = S) NR-, -SONR-, -NRSO-, -CROCR-, -CRSCR-, -CRNRCR-, Ctsiklogeteroalkilenovuyu group Ctsikloalkilenovuyu group Carilenovuyu group Cgeteroarilenovuyu group , an amino acid, a sugar or a monodisperse polyethylene glycol (PEG) structural unit each R is independently selected from H, Ci ^ alkyl, alkenyl, Calkinila, CalkoksiSalkila or gidroksiSalkila m represents an integer from 1 to 20.2. 2- [F] Ftoretiltriazol-linked analog of [Tyr] oktreotata selected from the group consisting of: FET-G-PEG-TOCA formula (Ib) :, FETE-PEG-TOCA formula (2b) :, FET-G-TOCA (3b) :, FETE-TOCA (4b): iFET-βAG-TOCA (5b) :, where each of the above compounds: R, iRimeet following structure: .3. 2- [F] Ftoretiltriazol-linked analog of [Tyr] oktreotata according to claim 1 or 2, wherein R is: .4. 2- [F] Ftoretiltriazol-linked analog of [Tyr] oktreotata representing FET-βAG- [Wc- (CTFTYC) K] (7b) :, wherein R a and R d is: .5. 2- [F] Ftoretiltriazol-linked analog of [Tyr] oktreotata according to claim 4, wherein R is: .6. A pharmaceutical composition comprising at least one compound of p.p.1-5 and a pharmaceutically acceptable carrier, excipient or biocompatible nositel.7. An alkyne-linked analog of [Tyr] oktreotata of formula (IV): wherein R a, R d following structure : iLINKER represents a linker group of formula - (A) -, wherein each A independently represents -CR, -CR = CR-, -S≡C-, -CRCO-, -COCR-, -NRCO-, -CONR-, - NR (C = O) NR-, -NR (C = S) NR-, -SONR-, -NRSO-, -CROCR-, -CRSCR-, -CRNRCR-, Ctsiklogeteroalkilenovuyu c1. 2-[18F]фторэтилтриазол-связанный аналог [Tyr3]октреотата формулы (III):,где R1 представляет собойR2 имеет следующую структуру:иЛИНКЕР представляет собой линкерную группу формулы -(A)m-, где
